Minerva Neurosciences, Inc.
USD4.68
-0.07 (-1.47%)
CEO
Remy Luthringer
IPO Date
2014-07-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.69
Prev. Close
$4.75
Day Low
$4.63
Day High
$4.97
52W Low
$1.57
52W High
$12.46
Market Cap
$0.03B
Volume
0.11M
| 0 |
| $0.00 |
| 1 Apr 2026 | Kaul Inderjit | director | A-Award | Acquired | 12,169 | $6.03 |
| 23 Dec 2025 | Kupfer David | director | A-Award | Acquired | 50,000 | $3.98 |
| 23 Dec 2025 | Kaul Inderjit | director | A-Award | Acquired | 364,504 | $3.98 |
| 23 Dec 2025 | HASLER HANS PETER | director | A-Award | Acquired | 50,000 | $3.98 |
| 23 Dec 2025 | Laghrissi-Thode Fouzia | director | A-Award | Acquired | 50,000 | $3.98 |
| 23 Dec 2025 | VAN HEEK G JAN | director | A-Award | Acquired | 50,000 | $3.98 |
| 23 Dec 2025 | Ahlholm Frederick W | SVP, CFO and Secretary | A-Award | Acquired | 500,000 | $3.98 |
| 23 Dec 2025 | Race Geoff | President | A-Award | Acquired | 1,500,000 | $3.98 |